By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relypsa, Inc. 

5301 Patrick Henry Drive

Santa Clara  California  95054  U.S.A.
Phone: 408-200-9500 Fax: n/a


Start Up

Company News
Relypsa, Inc. (RLYP) To Be Added To NASDAQ Biotechnology Index 12/17/2014 7:42:27 AM
Relypsa, Inc. (RLYP) Announces Stephen D. Harrison, M.A., Ph.D., Joins As Senior Vice President And Chief Scientific Officer 12/16/2014 7:50:59 AM
Relypsa, Inc. (RLYP) Announces FDA Acceptance Of New Drug Application For Patiromer For Oral Suspension To Treat Hyperkalemia 12/15/2014 7:23:13 AM
Relypsa, Inc. (RLYP) To Present At Oppenheimer 25th Annual Healthcare Conference 12/5/2014 10:56:48 AM
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 11/21/2014 2:50:12 PM
Relypsa, Inc. (RLYP) Announces Data Published In The New England Journal of Medicine For Pivotal Phase 3 Program Of Patiromer FOS For The Treatment Of Hyperkalemia 11/21/2014 11:20:05 AM
Relypsa, Inc. (RLYP) Announces Key Data Presented At American Society of Nephrology On Long-Term Chronic Treatment And Early Onset Of Action With Patiromer For Oral Suspension 11/17/2014 2:06:07 PM
Relypsa, Inc. (RLYP) To Present At Stifel Healthcare Conference 11/12/2014 10:18:34 AM
Relypsa, Inc. (RLYP) Announces Launch Of Educational Website To Advance U.S. Physicians' Awareness And Understanding Of Hyperkalemia 11/6/2014 1:10:51 PM
Relypsa, Inc. (RLYP) Announces Multiple Patiromer For Oral Suspension Abstracts To Be Presented At American Society of Nephrology Annual Meeting 2014 11/4/2014 7:46:05 AM